CFDE Data Portal | Search OCA2

	Label	Description
	OCA2 Gene (Entity type)	ENSG00000104044 - OCA2 melanosomal transmembrane protein
	OCA2 associations Collection (Entity type)	Associations for OCA2_associations
	OCA2 Gene (Entity type)	OCA2 melanosomal transmembrane protein [Source:HGNC Symbol;Acc:HGNC:8101]
	OCA2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	OCA2 YEAST Protein (Entity type)	Tyrosine-protein phosphatase-like protein OCA2
	GSE134191 3 V 1 METFORMIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE145195 PPP2R3B overexpression 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135030 3 V 10 FLUDARABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE149880 2 V 1 TAMOXIFEN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 10 V 6 TRAMETINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

OCA2

ENSG00000104044 - OCA2 melanosomal transmembrane protein

OCA2 associations

Associations for OCA2_associations

OCA2

OCA2 melanosomal transmembrane protein [Source:HGNC Symbol;Acc:HGNC:8101]

OCA2 associations.tsv

A file from IDG as part of the Harmonizome project

OCA2 YEAST

Tyrosine-protein phosphatase-like protein OCA2

GSE134191 3 V 1 METFORMIN MOUSE DN

A Gene Set from LINCS

GSE145195 PPP2R3B overexpression 0 v 1 human dn

A Gene Set from LINCS

GSE135030 3 V 10 FLUDARABINE HUMAN UP

A Gene Set from LINCS

GSE149880 2 V 1 TAMOXIFEN MOUSE DN

A Gene Set from LINCS

GSE213588 10 V 6 TRAMETINIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.